Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Nienke A Hesen"'
Autor:
Nienke A Hesen, Niels P Riksen, Bart Aalders, Michelle A E Brouwer, Merel Ritskes-Hoitinga, Saloua El Messaoudi, Kimberley E Wever
Publikováno v:
PLoS ONE, Vol 13, Iss 4, p e0195858 (2018)
[This corrects the article DOI: 10.1371/journal.pone.0183664.].
Externí odkaz:
https://doaj.org/article/76cfa438b8b547a8a796501a69821715
Autor:
Nienke A Hesen, Niels P Riksen, Bart Aalders, Michelle AE Brouwer, Merel Ritskes-Hoitinga, Saloua El Messaoudi, Kimberley E Wever
Publikováno v:
PLoS ONE, Vol 12, Iss 8, p e0183664 (2017)
Metformin improves cardiovascular prognosis in patients with diabetes mellitus, compared to alternative glucose-lowering drugs, despite similar glycemic control. Direct cardiovascular protective properties have therefore been proposed, and studied in
Externí odkaz:
https://doaj.org/article/d818ad21e724471396c52d511761ad04
Autor:
Ling Xiao, Thea Leusink-Muis, Nienke Kettelarij, Ingrid van Ark, Bernadet Blijenberg, Nienke A. Hesen, Bernd Stahl, Saskia A. Overbeek, Johan Garssen, Gert Folkerts, Belinda van’t Land
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
Frontiers in Immunology
Frontiers in Immunology, 9. Frontiers Media S.A.
Frontiers in Immunology
Frontiers in Immunology, 9. Frontiers Media S.A.
Background: Human milk is uniquely suited to provide optimal nutrition and immune protection to infants. Human milk oligosaccharides are structural complex and diverse consisting of short chain and long chain oligosaccharides typically present in a 9
Autor:
Niels P. Riksen, Merel Ritskes-Hoitinga, Kimberley E. Wever, Saloua El Messaoudi, Michelle A. E. Brouwer, Bart Aalders, Nienke A. Hesen
Publikováno v:
PLoS ONE
PLoS One, 12
PLoS ONE, Vol 12, Iss 8, p e0183664 (2017)
PLoS One, 12, 8
PLoS One, 12
PLoS ONE, Vol 12, Iss 8, p e0183664 (2017)
PLoS One, 12, 8
Contains fulltext : 177026.pdf (Publisher’s version ) (Open Access) Metformin improves cardiovascular prognosis in patients with diabetes mellitus, compared to alternative glucose-lowering drugs, despite similar glycemic control. Direct cardiovascu